The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection
Depression represents a major public health problem. It is estimated that 13-20% of the population has some depressive symptoms at any given time. The biological process of inflammation is compatible with the waxing and waning course of depression, and could explain the biology of this disorder. Over the years a body of evidence has been accumulated that suggests that major depression is associated with signs of immunologic dysfunction. Moreover, it has been hypothesized that cytokine hypersecretion may be involved in the etiology of depressive disorders. Evidence suggests that major depression commonly co-occurs with ischemic heart disease and decreased bone mineral density. Depressive symptoms are known to have a negative impact on cardiovascular prognosis, increasing the mortality rate of coronary artery disease. Several lines of evidence indicate that brain cytokines, principally interleukin-1␤ (IL-1␤) and IL-1 receptor antagonist may have a role in the biology of major depression, and that they might additionally be involved in the pathophysiology and medical consequences of depression as well as in the effects of antidepressant treatment.
Cytokines and depression: fortuitous or causative association? R Dantzer, EE Wollman, L Vitkovic, R Yirmiya
Although it is commonly thought that mental depression is associated with immune depression, recent evidence points to the possibility that at least some forms of depression are associated with biological signs of immune activation due to an enhanced production of cytokines by accessory immune cells of the monocyte/macrophage lineage and certain categories of T cells. This, coupled with the fact that administration of these cytokines to non psychiatric patients and laboratory animals induces psychological, behavioral, neurochemical and neuroendocrine alterations comparable to those observed in depression and alleviable by chronic anti-depressant treatment, had led to the hypothesis that cytokines might play a causative role in the pathophysiology of depression. Based on a recent discussion meeting in France, the present perspective article critically examines the type of clinical and experimental evidence that is still needed for fully understanding the psychopathological implications of the intersection between cytokines and depression.
MECHANISMS OF DRUG ACTION
The experimental and clinical pharmacology of St John's Wort (Hypericum perforatum L.) PJ Nathan, C Chem Hypericum (St John's Wort) is a plant that has been used for centuries as a medicinal herb. Experimental studies show that hypericum has antidepressant properties in animal models of depression. Furthermore the mechanism by which this antidepressant effect is exerted has been shown to be similar to many standard antidepressants. Supporting the pre-clinical studies, a number of clinical studies have shown that hypericum is an effective antidepressant for the treatment of mild-to-moderate depression. Studies conducted in patients with mild-to-moderate depression show that hypericum has a better antidepressant effect than placebo and a comparable antidepressant effect to standard antidepressants. The advantage of hypericum over other antidepressants may result from its favorable side-effect profile. Although evidence suggests that hypericum may have an antidepressant effect for the short-term treatment of mild-to-moderate depression, its benefit in the long-term requires further investigation.
IMMEDIATE COMMUNICATION

High throughput fluorescent CE-SSCP SNP genotyping
The study of complex diseases involving multiple loci requires a dense genetic map and a large sample size. Single nucleotide polymorphisms (SNPs) are preferred for several gene mapping approaches, as their high frequency in the genome places them in close proximity of various genes of interest. For studies utilizing a multiplicative gene model to be feasible, these polymorphisms must be efficiently genotyped. A method is described for high-throughput genotyping of SNPs by single stranded conformational polymorphism analysis of pooled PCR products using automated capillary electrophoresis with laser-induced fluorescence. This technology allows laboratories to employ individualized marker panels for regions or genes of interest.
ORIGINAL RESEARCH ARTICLES
Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and ␣ 2 -adrenergic agonists SH Kim, MT Price, JW Olney, NB Farber MK-801, ketamine and PCP block NMDA receptors in the brain and thus are called NMDA antagonists. NMDA antagonists can injure certain neurons in the brain of rodents. It has been proposed that the injury occurs as a result of excessive release of two neurotransmitters, acetylcholine and glutamate. In this study the authors confirmed that NMDA antagonists do cause acetylcholine to be excessively released at the site of injury. In addition they found that other drugs that can prevent the neuronal injury caused by NMDA antagonists can also block this excessive release of acetylcholine. The results are consistent with their proposal that blockade of NMDA receptors interferes with the brain's normal ability to inhibit the firing of certain neurons. These results could be important for Alzheimer's disease and schizophrenia where loss of this inhibitory capacity may play a central role in the disease process.
Autosome search for schizophrenia susceptibility genes in multiply affected families MI Rees, I Fenton, NM Williams, P Holmans, N Norton, A Cardno, P Asherson, G Spurlock, E Roberts, E Parfitt, R Mant, H Vallada, E Dawson, M-W Li, DA Collier, JF Powell, S Nanko, M Gill, P McGuffin, MJ Owen
The authors analyzed 298 polymorphic markers in 13 families multiply affected with schizophrenia and related disorders using a combination of radiolabelled and fluorescent-based methodologies. The markers were distributed throughout the autosomes at an average spacing of 12.8 cM. The data were analyzed with two-point linkage analysis (MLINK) and heterogeneity testing (HOMOG). Several genetic models were used ranging from near dominant to fully recessive. Multipoint analysis was performed for 27 regions demonstrating either contiguously positive lod scores in two or more consecutive markers, and in regions with twopoint lod score(s) of 1.0 or above in a single marker. A proportion of the multi-point regions has been implicated in previous studies, thereby decreasing risk of false-positive results. However neither the two-point, nor multi-point scores reached the threshold value for significance of 3.6. Nevertheless three regions were suggestive of linkage.
Identification of four variants in the tryptophan hydroxylase promoter and association to behavior A Rotondo, KE Schuebel, AW Bergen, R Aragon, M Virkkunen, M Linnoila, D Goldman, DA Nielsen One of the most replicated findings in biological psychiatry is the observation of lower 5-hydroxyindoleacetic acid (5-HIAA) concentrations, the major metabolite of serotonin, in the brain and cerebrospinal fluid (CSF) of subjects with impulsive aggression directed against others or self. Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in the synthesis of 5-HT, however functional variants have not been reported from the coding sequence of this gene. Therefore, the authors screened for genetic variants of the human TPH promoter (TPH-P), that may modulate TPH gene transcription. Four common polymorphisms were identified: −1720TϾG, −1605ϾT, −1066AϾG, and −346GϾT. A significant association was observed between −1066AϾG and suicidality in a sample of Finnish violent offenders. These results provide evidence that genetic variation of the TPH promoter region could predispose individuals to suicidality.
Dopamine D4 receptor (D4DR) and serotonin transporter promoter (5-HTTLPR) polymorphisms in the determination of temperament in 2-month-old infants J Auerbach, V Geller, S Lezer, E Shinwell, RH Belmaker, J Levine, RP Ebstein
In a study of 2-month-old infants followed longitudinally from birth, the authors found further evidence of an association between early temperament and two genes, the dopamine D4 receptor, D4DR, and the serotonin-transporter promotor region, 5-HTTLPR that have been associated with adult personality traits. Infants with long D4DR alleles were reported as showing less negative emotionality and less distress in daily situations than infants with short D4DR alleles. Infants with the homozygous short form (s/s) of 5-HTTLPR were reported as showing more negative emotionality and more distress in daily situations than infants with other genotypes. The strongest effect occurred in infants with s/s 5-HTTLPR who were lacking the long D4DR alleles. These infants showed most negative emotionality and most distress to daily situations. These findings suggest that antecedents of adult personality traits may be observed in infancy although the particular genes they studied explain only a small portion of the variance in the traits noted.
Potential role of the estrogen receptor gene (ESR1) in anxiety DE Comings, D Muhleman, P Johnson, JP MacMurray
In addition to neurotransmitters, hormones, acting through the blood stream, also play a role in behavior. To test the potential contribution of genetic variations in hormone receptors we have examined the association between the alleles of a repeat polymorphism of the estrogen receptor gene (ESR1) and subscores of the SCL-90 screening test for psychiatric symptoms, in a group of 179 adult males treated for substance abuse. Based on our prior hypothesis that the length of repeat polymorphisms may play a direct role in gene regulation, the alleles were divided into two groups, short (S) and long (L). There was a significant association between the three genotypes at ␣ Յ 0.05 for anxiety, phobic anxiety, and total symptom count. The anxiety score was most significant (P Յ 0.005). By regression analysis, the ESR1 gene accounted for 7% of the variance of the anxiety score (P Յ 0.0004). These results are consistent with a role of genetic variants of the estrogen receptor gene in human behavior.
Association between the dopamine D4 receptor (DRD4) exon III polymorphism and measures of novelty seeking in a German population A Strobel, A Wehr, A Michel, B Brocke
Since the observation of an association between the dopamine D4 receptor (DRD4) exon III polymorphism and the temperament trait of Novelty Seeking by Ebstein and his colleagues, replication studies have yielded both positive and negative results. Because demographic or methodological differences between studies may have obscured the small effect of the DRD4 polymorphism on Novelty Seeking, the initial findings were replicated as precisely as possible. A cohort of 136 healthy, young German volunteers was genotyped, and Novelty Seeking was assessed with the TPQ. Further aspects of novelty seeking behavior were ascertained through additional trait measures. The reported association could be observed: long DRD4 alleles were significantly associated with elevated scores on the TPQ-Novelty Seeking total scale as well as on two of the subscales, Exploratory Excitability and Extravagance. The results provide further confirmation for the role of the DRD4 exon III polymorphism in modulation of Novelty Seeking. In addition, the pattern of associations between the polymorphism and other scales suggests that this polymorphism has its effect on exploratory, extravagant, and extraverted, rather than on impulsive and monotony-avoidant subtypes of Novelty Seeking.
Association between low activity serotonin transporter promoter genotype with habitual impulsive violent behavior among antisocial early onset alcoholics T Hallikainen, TA Saito, HM Lachman, J Volavka, T Pohjalainen, O-P Ryynä nen, J Kauhanen, E Syvä lahti, J Hietala, J Tiihonen A common biallelic functional polymorphism in the promoter region of the human serotonin transporter (5-HTT) gene affects this gene's expression so that the short (S) allele is less active than the long (L) allele. On the basis of strong evidence of the disturbed serotonergic transmission among antisocial, impulsive and habitually violent type 2 alcoholics, the authors have studied these genotypes and allele frequencies among 51 impulsive violent recidivistic offenders with type 2 alcoholism, 114 late-onset non-violent type 1 alcoholics and 54 healthy controls. The frequency of the S allele was significantly higher among type 2 alcoholics when compared with healthy controls and type 1 alcoholics suggesting that the 5-HTT S promoter polymorphism is associated with an increased risk for early onset alcoholism associated with antisocial personality disorder and impulsive, habitual violent behavior.
Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways A Frisch, D Postilnick, R Rockah, E Michaelovsky, S Postilnick, E Birman, N Laor, B Rauchverger, A Kreinin, M Poyurovsky, M Schneidman, I Modai, R Weizman Major depressive disorder (MDD) is a severe psychiatric disorder with a lifetime prevalence of about 15%. The importance of the genetic component is well accepted, but the mode of inheritance is complex and non-Mendelian. A line of evidence suggests the involvement of serotonin and dopamine neurotransmitters in the pathophysiology of depression. In the present study, 102 unipolar MDD patients and 172 healthy controls were genotyped for polymorphisms in four serotonergic and three dopaminergic candidate genes. There were no statistical differences between MDD patients and healthy controls in genotypic and allelic distribution of all seven polymorphisms investigated. Thus, this study does not support a major role for these polymorphisms in contributing to susceptibility to MDD, although it does not preclude minor effects.
A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders H Kunugi, S Ishida, T Kato, M Tatsumi, T Sakai, M Hattori, T Hirose, S Nanko
Monoamine oxidase-A (MAOA) catalyzes biogenic amines and plays a critical role in the regulation of catecholamine and indolamine neurotransmission. A polymorphism of variable number of tandem repeat (VNTR), which was recently found in the promoter region of the MAOA gene, was shown to be associated with its transcriptional activity. The present study examined whether this functional polymorphism is associated with the risk of developing mood disorders in a Japanese sample of 164 patients with bipolar disorder, 98 with unipolar depression, and 258 controls. There was no significant genotypic or allelic association, suggesting that the VNTR polymorphism in the MAOA gene is unlikely to play a major role in the pathogenesis of bipolar disorder or unipolar depression. Furthermore, there was no significant association between the polymorphism and a history of suicide attempt.
